Since January 2019, CBD has sat on the EU's Novel Food list under Regulation (EU) 2015/2283 — no member state has authorised it, and none currently can. EFSA's February 2026 provisional safe intake figure (roughly 2mg/day for a 70kg adult) is a safety opinion, not an authorisation.
Ireland applies that regime directly, with national enforcement provisions and no Irish derogation, public list or transitional window. Cannabidiol itself is expressly not a controlled drug in Ireland: the Food Safety Authority of Ireland states that CBD is not considered a narcotic drug and is not a controlled drug under the Misuse of Drugs Act 1977, and the Minister for Health confirmed the same in a written Dail answer in 2025.
What controls a CBD product in Ireland is what else is in it. A full-spectrum hemp extract contains cannabinol, which is named in the Schedule to the Misuse of Drugs Act 1977, and trace delta-9-THC, which is controlled as a cannabinol derivative at any proportion; and the State charges hemp extracts as cannabis and cannabis resin, as it did in the case decided by the High Court in July 2024. The finished product is therefore a controlled drug in Ireland notwithstanding CBD's own status.